101
Views
0
CrossRef citations to date
0
Altmetric
Nutrition and the brain - Review article

Association of vitamin B12, folate, homocysteine and cognition in the elderly

Pages 132-138 | Received 27 Jan 2003, Accepted 11 Apr 2003, Published online: 13 Dec 2016

References

  • Herbert V. Vitamin B12: plant sources, requirements, and assays. Am J Clin Nutr 1988; 48: 852–8.
  • Lee R. Nutritional factors in the production and function of erythrocytes. In: Lee R, et al, eds. Wintrobe’s clinical hematology, 9th edn. Philadelphia, PA: Lea & Febiger; 1993.
  • Hultdin J. Vitamin B12. Molekyl, metabolism och markörer. In: Engstedt L, et al, eds. Kontroverser kring vitamin B12. Kunskap, kompetens, kommunikation. Klippan: Pedagogförlaget; 1998. p. 23-49.
  • Wintrobe MM. Blood, pure and eloquent. New York: McGraw-Hill; 1980.
  • Lökk J. Folat/B12-berikning av läkarkaren lämplig t ämne pa nästa läkarstämma. Läkartidningen 2002; 10: 1105.
  • Rajan S, et al. Screening for cobalamin deficiency in geriatric outpatients: prevalence and influence of synthetic cobalamin intake. J Am Geriatr Soc 2002; 50: 624–6230.
  • Haller J. The vitamin status and its adequacy in the elderly: an international review. Int J Vitam Nutr Res 1999; 69: 160–8.
  • Hvaas A-M. Diagnostik og behandling af vitamin B12 mangel. Akademisk avhandling, Det sundhedsvidenska-belige Fakultet, Aarhus Universitet, Denmark; 2001.
  • Nygard O, et al. Plasma total homocysteine and cardiovascular and non-cardio-vascular mortality: the Hordaland study. Am J Clin Nutr 2001; 74: 103-36.
  • Selhub J, et al. Vitamin status and intake as primary determinants of hyperhomocysteinemia in an elderly population. JAMA 1993; 270: 2693–8.
  • Finkelstein JD. Homocysteine: a history in progress. Nutr Rev 2000; 58: 193–204.
  • Schneede J, et al. Biological and environmental determinants of plasma homocysteine. Semin Thromb He-most 2000; 26: 263–79.
  • Kang S, et al. Intermediate hyperhomocysteinemia resulting from compound heterozygosity of MTHFR mutation. Am J Hum Genet 1991; 48: 546–51.
  • Bolander-Gouaille C. Focus on homocysteine and the vitamins involved in its metabolism. Frankrike: Springer; 2002.
  • Lökk J. Folat/kobalamin hos äldre - bristtillstand vanliga och svarlangade. Läkartidningen 2002; 98: 5878–82.
  • Rosenberg IH, et al. Nutritional factors in physical and cognitive functions of elderly people. Am J Clin Nutr 1992; 55: 12375–43S.
  • Wang HX. Vitamin B12, folate, and Alzheimer’s disease. Drug Dev Res 2002; 56: 111–22.
  • Selhub J, et al. Association between plasma homocys-teine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995; 332: 286–91.
  • Schnyder G, et al. Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention. JAMA 2002; 288: 973–9.
  • Molloy AM. Folate bioavailability and health. Int J Vitamin Nutr Res 2002; 72: 5221–46.
  • Czeizel AE. Prevention of congenital abnormalities by periconceptional multivitamin supplementation. Br Med J 1993; 306: 1645–9.
  • Wald NJ, et al. Quantifying the effect of folic acid. Lancet 2001; 358: 2069–73.
  • Munoz-Maan E, et al. Genetic selection and folate intake during pregnancy. Lancet 1998; 352: 1120–1.
  • Penninx BWJH, et al. Vitamin B12 deficiency and depression in physically disabled older women: epidemiologic evidence from the Women’s Health and Aging Study. Am J Psychiatry 2000; 157: 715–21.
  • Choi SW, Mason JB. Folate and carcinogenesis: an integrated scheme. J Nutr 2002; 132(Suppl S): 129-32.
  • Backman DL, et al. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham study. Neurology 1992; 42: 115–9.
  • Lökk J, Sandström H. Mentala symtom vid B12-brist - Geriatrikerns och distriktsläkarens perspektiv. In: Engstedt L, et al., eds. Kontroverser kring vitamin B12: Kunskap, kompetens, kommunikation. Klippan, Sverige: Pedagogförlaget; 1998.
  • Joosten E, et al. Metabolic evidence that deficiencies of vitamin B12, folate, and vitamin B6 occur commonly in elderly people. Am J Clin Nutr 1993; 58: 468–76.
  • McCaddon A, Davies G. Nutritionally independent B12 deficiency and Alzheimer disease. Arch Neurol 2000; 57: 607–8.
  • Parnetti L, et al. Role of homocysteine in age-related vascular and non-vascular diseases. Aging Clin Exp Res 1997; 9: 241–57.
  • Fontanari D, et al. Effects of SadenosylLmethionine on cognition and vigilance functions in the elderly. Curr Ther Res 1994; 55: 682–99.
  • Lindenbaum J, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988; 318: 1720–8.
  • Gottfries J, et al. One-carbon metabolism and other biochemical correlates of cognitive impairment as visualized by principal component analysis. J Geriatr Psychiatry Neurol 2001; 14: 109–14.
  • Leblhuber F, et al. Hyperhomocysteinemia in dementia. J Neural Transm 2000; 107: 1469–74.
  • Franchi F, et al. Deficient folate nutritional status and cognitive performances: results from a retrospective study in male elderly inpatients in a geriatric department. Arch Gerontol Geriatr 2001; 7 (Suppl): 145-50.
  • Wang HX, et al. Vitamin B12 and folate in relation to the development of Alzheimer’s disease. Neurology 2001; 56: 188–94.
  • Ikeda T, et al. Vitamin B12 levels in serum and cerebrospinal fluid of people with Alzheimer’s disease. Acta Psychiatr Scand 1990; 82: 327–9.
  • Riggs K, et al. Relations of vitamin B12, B6, folate and homocysteine to cognitive performance in the normative aging study. Am J Clin Nutr 1996; 63: 306–14.
  • Jensen E, et al. Plasma homocysteine in 80-year-olds. Relationships to medical, psychological, and social variables. Arch Gerontol Geriatr 1998; 26: 215–26.
  • Budge M, et al. Plasma total homocysteine and cognitive performance in a volunteer elderly population. Ann N Y Acad Sci 2000; 903: 407–10.
  • Clarke RT, et al. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer’s disease. Arch Neurol 1998; 55: 1449–155.
  • McCaddon A, et al. Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry 1998; 13: 235–9.
  • Lehmann M, et al. Identification of cognitive impairment in the elderly. Homocysteine is an early marker. Dement Geriatr Cogn Disord 1999; 10: 12–20.
  • Nilsson K, et al. The plasma homocysteine concentration is better than that of serum methylmalonic acid as a marker for sociopsychological performance in a psycho-geriatric population. Clin Chem 2000; 46: 691–6.
  • Johnson MA, et al. Hyperhomocysteinemia and vitamin B12 deficiency in elderly using Title IIIc nutrition services. Am J Clin Nutr 2003; 77: 211–20.
  • Maxwell CJ, et al. Serum folate levels and subsequent adverse cerebrovascular outcomes in elderly persons. Dement Geriatr Cogn Disord 2002; 13: 225–34.
  • McCaddon A, et al. Homocysteine and cognitive decline in healthy elderly. Dement Geriatr Cogn Disord 2001; 12: 309–13.
  • Seshadri S, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med 2002; 346: 476–83.
  • Prins ND, et al. Homocysteine and cognitive function in the elderly - the Rotterdam Scan Study. Neurology 2002; 59: 1375–80.
  • Duthie SJ, et al. Homocysteine, B vitamin status, and cognitive function in the elderly. Am J Clin Nutr 2002; 75: 908–13.
  • van Asselt D, et al. Cobalamin supplementation improves cognitive and cerebral function in older, cobala-min-deficient persons. J Gerontol 2001; 56A: M775–9.
  • Martin D, et al. Time dependency of cognitive recovery with cobalamin replacement: report of a pilot study. J Am Geriatr Soc 1992; 40: 168–72.
  • Nilsson K, et al. Improvement of cognitive function after cobalamin/folate supplementation in elderly persons with dementia and elevated plasma homocysteine. Int J Geriatr Psychiatry 2001; 16: 609–14.
  • Nilsson K, et al. Treatment of cobalamin deficiency in dementia, evaluated clinically and with cerebral blood flow measurements. Aging Clin Exp Res 2000; 12: 199–207.
  • Kuzminsky M, et al. Effective treatment of cobalamin deficiency with oral cobalamin. Blood 1998; 92: 1191–8.
  • Clarke RT. An overview of homocysteine lowering trials. In: Robinson K, ed. Homocysteine and causality discussion. Dordrecht: Kluwer Academic; 2000. p. 213-29.
  • Stabler SP. Screening the older population for cobalamin (vitamin B12) deficiency. J Am Geriatr Soc 1995; 32: 1290–7.
  • Lindgren A. On the diagnosis of cobalamin malabsorption. Akademisk avhandling, Medicinska Institutionen, Göteborgs Universitet; 1998.
  • Bates CJ, et al. Relationship between methylmalonic acid, homocysteine, vitamin B12 intake and status and socio-economic indices, in a subset of participants in the British National Diet and Nutrition Survey of peopleaged 65 y and over. Eur J Clin Nutr 2003; 57: 349–57.
  • Anonymous. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists’ Collaboration. Br Med J 1998; 316: 894–8.
  • Garcia A, et al. Is low-dose oral cobalamin enough to normalize cobalamin function in older people? J Am Geriatr Soc 2002; 50: 1401–4.
  • Refsum H, et al. Homocysteine and cardiovascular disease. Annu Rev Med 1998; 49: 31–62.
  • FASS (Farmaceutiska specialiteter i Sverige). Kungs-backa: Elanders; 2002.
  • Nilsson K, et al. Optimal use of markers for cobalamin and folate in a psychogeriatric population. Int J Geriatr Psychiatry 2002; 17: 919–25.